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Abstract
To determine the aetiological role and epidemiological proﬁle of common respiratory viruses in adults with acute respiratory tract
infections (ARTIs), a 2-year study was conducted in Beijing, China, from May 2005 to July 2007. Nose and throat swab samples from
5808 ARTI patients were analysed by PCR methods for common respiratory viruses, including inﬂuenza viruses (IFVs) A, B, and C, para-
inﬂuenza viruses (PIVs) 1–4, enteroviruses (EVs), human rhinoviruses (HRVs), respiratory syncytial virus (RSV), human metapneumovirus
(HMPV), human coronaviruses (HCoVs) OC43, 229E, NL63, and HKU1, and adenoviruses (ADVs). Viral pathogens were detected in
34.6% of patient samples, and 1.6% of the patients tested positive for more than one virus. IFVs (19.3%) were the dominant agents
detected, followed by HRVs (6.5%), PIVs (4.3%), EVs (3.2%), and HCoVs (1.1%). ADVs, RSV and HMPV were also detected (<1%). The
viral detection rates differed signiﬁcantly between infections of the lower and upper respiratory tracts in the sample population: PIVs,
the second most commonly detected viral agents in lower acute respiratory tract infections (LRTIs), were more prevalent than in upper
acute respiratory tract infections, indicating that the pathogenic role of PIVs in LRTIs should be investigated. Currently, this study is the
largest-scale investigation of respiratory virus infections in China with multiple agent detection, providing baseline data for further
studies of respiratory virus infections in adults with ARTIs.
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Introduction
Viruses are among the major causes of acute respiratory
tract illnesses (ARTIs) throughout the world. The most
common viruses responsible for ARTIs include inﬂuenza
viruses (IFVs), respiratory syncytial virus (RSV), parainﬂuenza
viruses (PIVs) 1–4, enteroviruses (EVs), human rhinoviruses
(HRVs), adenoviruses (ADVs), and human coronaviruses
(HCoVs) 229E and OC43 [1–4]. Improvements in molecular
detection techniques have resulted in the recent identiﬁca-
tion of several new respiratory viruses [5]. Recently discov-
ered viruses such as human metapneumovirus (HMPV), novel
strains of coronaviruses (SARS-CoV, HCoV-NL63, and
HKU1), human bocavirus and novel polyomaviruses (WU
and KI) have been detected around the world [5–14]. The
illness and mortality due to respiratory viruses have made
viral ARTIs a top priority in the global health challenge. As
vaccination is currently unavailable for most of these viruses,
it is necessary to monitor epidemic patterns and investigate
the spread of respiratory virus infections to efﬁciently iden-
tify, control and prevent future epidemics.
Viral emergence varies from season to season, year to
year, and region to region [15]. The risk of respiratory virus
infection correlates with age, pre-existing medical condition,
and immune status [16,17]. Most studies of respiratory viral
activity patterns have focused on children, and large-scale
epidemiological investigations of respiratory virus infections
in adults have rarely been conducted. In an attempt to
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characterize the respiratory virus infections and to provide
insights into the aetiology and clinical associations of respira-
tory viruses in adult ARTIs, a 2-year study was conducted
with adults suspected of having ARTIs in Beijing, China.
Materials and Methods
Patients and clinical specimens
Recruitment of patients took place from May 2005 to July
2007 at the Fever Outpatient Clinic Department (FOCD) of
the Peking Union Medical College Hospital (PUMCH), Beij-
ing, China. To include the potential viral ARTIs and to
exclude typical bacterial infections, patients enrolled in the
study were selected by physicians according to the following
criteria: ‡14 years of age, with respiratory symptoms such as
cough or wheezing, acute fever (body temperature ‡38C),
and normal or low leukocyte count, with or without radio-
logical pulmonary abnormalities. Nose and throat swabs
were collected from each patient, and the two swabs were
pooled in one tube containing virus transport medium (VTM;
Copan, Brescia, Italy). A total of 5808 patient samples
(i.e. c. one-third of the patients who visited the FOCD of
PUMCH during the study period) were collected and tested.
Nucleic acid extraction
Total nucleic acids (DNA and RNA) were extracted from
200 lL of each specimen (VTM) using the NucliSens easy-
MAG apparatus (bioMe´rieux, Marcy l’Etoile, France), accord-
ing to the manufacturer’s instructions [18].
Molecular detection of respiratory viruses
The presence of RSV, IFVs A, B, and C, PIVs 1–4, HRVs,
EVs, HCoVs (229E, OC43, NL63, and HKU1), HMPV and
ADVs was determined by PCR assays, as previously reported
[1,19–22], and the details of these assays are summarized in
Table 1. Brieﬂy, two multiplex nested RT-PCRs were used
for the simultaneous detection of PIVs 1–4, EVs, and HRVs,
as well as IFVs A, B, and C, and RSVs A, and B. In addition,
two one-step RT-PCRs were used to detect HCoVs and
HMPV. ADVs were detected by one-step PCR. The sensitiv-
ity of the PCR systems was determined by using cloned,
ampliﬁed products of each type of virus. Blank VTM was
used as a negative control, and 100 copies of invariant
b-actin gene were added to lysis buffer as internal controls
to exclude inhibitors for nucleic acid extraction and PCR.
Each RT-PCR ampliﬁcation was performed using the
SuperScript II One-Step RT-PCR Platinum Taq kit
(Invitrogen), and ExTaq DNA polymerase (Takara) was used
for PCR assays. PCR products were analysed by electropho-
resis in 2% agarose gel containing ethidium bromide. Of the
PCR-positive samples, half were randomly selected for veriﬁ-
cation by PCR product sequencing.
Statistical analysis
Comparison among groups was performed using a chi-square
test with a signiﬁcance level of p <0.05.
Results
Overall detection of respiratory viruses
The investigation was performed on working days from May
2005 to July 2007, with the exception of July and November
2005, when clinical samples were not collected. Between 11
and 54 (average 33) patients per day were diagnosed with
ARTIs at the FOCD, PUMCH during the study period. On
average, ten patients with ARTIs were selected each day,
according to the criteria described in Materials and Methods,
providing 5808 patients in total. Patient ages ranged between
14 and 97 years (median, 30 years; mean, 35.7 years). Speci-
mens were collected from both females (3137, 54.0%) and
males (2671, 46.0%). The sensitivity of detection of viruses
was as follows: 1–10 molecules for PIVs 2 and 4, EVs, HRVs,
IFVs A, B, and C, RSVs A and B, HMPV and ADVs; and
10–100 molecules for PIVs 1 and 3, and HCoVs.
Respiratory samples from 2010 (34.6%) patients were
found to be positive for at least one virus, and those from
3798 (65.4%) patients were negative for all respiratory
viruses tested. Pathogens in such patients as these need to
be further investigated. The monthly detection rates of respi-
ratory viruses ranged from 12.7% to 69.8% of patients tested
(Fig. 1). There were no signiﬁcant differences between
viruses infecting men and women (data not shown). All of
the common respiratory viruses were detected. As
expected, IFV infection was dominant, being detected in
1119 (19.3%) patients. The detection rate of HRVs was 6.5%,
and those of other viruses were as follows: PIVs, 4.3%; EVs,
3.2%; and HCoVs, 1.1%. ADVs, RSV and HMPV were rarely
detected, displaying positivity rates of <1% (Table 2).
Seasonality of respiratory virus infection
IFV A was detected at the highest frequency and throughout
the study period. Two major peaks were observed: in a per-
iod from July to September 2006, and in a period from
December 2006 to February 2007. Three minor IFV A
peaks were observed in a period between August and Sep-
tember 2005, in December 2005, and in March 2006
(Fig. 2a). Unlike IFV A, IFV B is active in spring in Beijing.
Apart from two distinct peaks in March and April of 2006
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and 2007, rates of IFV B infection were low throughout the
study period. The IFV B peaks occurred following IFV A
peaks, indicating that epidemic peaks may alternate between
IFVs A and B in Beijing (Fig. 2a). IFV C (15 patients, 0.3%)
was rarely detected.
HRVs were the second most frequently detected viral
agents, and presented during nearly the entire year, lacking
regular seasonality. These ﬁndings indicate the important role
of HRVs in adult ARTIs (Fig. 2b).
PIV infection varied in incidence between the 2 years of the
study (Fig. 2c). PIVs were not detected in November 2006
and February 2007, and a distinct PIV peak was observed in
the spring (April and May) of 2006. The incidence of EVs was
low between December and March in both 2005 and 2006;
indeed, EVs were not detected during February of each year.
More cases of EV were found in early summer (June of 2005
and 2007, and July of 2006 and 2007) (Fig. 2d).
HCoVs were detected in only (1.1%) 65 patients, with
HCoV-OC43 being most frequent. They appeared sporadi-
cally during the study years, but an epidemic peak occurred
in June 2007(Fig. 2e).
Respiratory virus detection among different age groups
IFVs were the most frequent respiratory viruses affecting all
age groups tested, especially those £65 years of age. Detec-
tion rates for EVs, HRVs and ADVs were higher in the 14–
25-year age group, whereas HCoVs, RSV and HMPV were
detected mainly in elderly adults (Table 2).
Co-detection of respiratory viruses
Among the positive cases, multiple (‡2) respiratory viruses
were observed in 94 patients. Dual infections were present
in 93 of these patients, with triple infections being found in
one patient (Table 3). HRVs, detected in 52 cases, were
the most frequently found viral agents in co-infections. IFV
A was co-detected in 39 cases, PIVs in 29, EVs in 23, IFV
B in 23, HCoVs in eight, ADVs in six, HMPV in three,
IFV C in ﬁve, and RSV in one. Co-infections were signiﬁ-
cantly more frequent in younger and older groups than in
the 26–65-year age group (£25 years, p 0.013; ‡66 years,
p 0.008).
Association of respiratory viruses with lower and upper
ARTIs
Among the 5808 patients affected by ARTIs, 276 (4.8%)
had lower ARTIs (LRTIs) (e.g. pneumonia) and 5532
(95.2%) had upper ARTIs (URTIs) (e.g. rhinitis, pharyngitis,
or laryngitis) (Table 4). The relative occurrence of LRTIs
and URTIs was not signiﬁcantly different among the age
groups. IFVs, PIVs and HRVs were the main pathogens
involved in both LRTIs and URTIs. A chi-square test
showed that IFV A had a greater tendency to cause URTIs
(p 0.010), whereas PIVs tended to cause LRTIs (p 0.015).
This observation indicates that more attention should be
paid to the pathogenicity of PIVs in addition to IFVs.
Discussion
The accurate and rapid analysis of a broad range of viral
agents is critical for aetiological investigations. In this study,
multiple viral agents, including IFVs A, B, and C, RSV, PIVs
1–4, HRVs, EVs, HCoVs (229E, OC43, NL63, and HKU1),
HMPV, and ADVs, were analysed in a large population, with
the goal of providing comprehensive data for viral infection
in adults with ARTIs. To our knowledge, this is the largest-
scale investigation of respiratory virus infections in China in
adults with ARTIs. The overall detection rate of respiratory
viruses in this study was 34.6%, similar to those obtained by
others [2,3]. However, these results may underestimate the
role of virus infection, because viral loads in nose and throat
swabs, as used in this study, are usually lower than those in
TABLE 2. Distribution of respiratory virus infections according
to age groups
Age group (years)
14–25 26–65 ‡66 Total
Patientstested (no.) 1918 3434 456 5808
IFVs 384 (20.0)a 667 (19.4) 68 (14.9) 1119 (19.3)
HRVs 152 (7.9) 197 (5.7) 27 (5.9) 376 (6.5)
PIVs 89 (4.6) 136 (4.0) 27 (5.9) 252 (4.3)
EVs 84 (4.4) 95 (2.8) 9 (2.0) 188 (3.2)
HCoVs 18 (0.9) 27 (0.8) 20 (4.4) 65 (1.1)
ADVs 31 (1.6) 19 (0.6) 1 (0.2) 51 (0.9)
RSV 2 (0.1) 19 (0.6) 9 (2.0) 30 (0.5)
HMPV 4 (0.2) 10 (0.3) 5 (1.1) 19 (0.3)
ADV, adenovirus; EV, enterovirus; HCoV, human coronavirus; HMPV, human
metapneumovirus; HRV, human rhinovirus; IFV, inﬂuenza virus; PIV, parainﬂu-
enza virus; RSV, respiratory syncytial virus.
aNumbers in parentheses are percentages.
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FIG. 1. Numbers of patients tested and numbers with positive virus
detection for each month of the investigation.
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aspirate or lavage [23]. Furthermore, infections from as yet
unknown viruses may be responsible for some ARTIs. The
prevalence of bacterial ARTI was not investigated in this
study.
Some of the tested known viruses, such as HRVs and
RSV, were detected at lower rates than those reported by
other investigators [24,25]. There are multiple explanations
for these differences. First, detection methods differ from
one study to another. It is difﬁcult to compare the results,
as the reported data were obtained with different detec-
tion methods or PCR primers [2,24]. Future comparative
studies to evaluate the sensitivity and speciﬁcity of these
detection methods should clarify this issue. Second, the
infection rates may vary with geographical location, and
with the particular period chosen for testing [15,24].
Third, the patient population and its environment may
inﬂuence the results. Previous studies on RSV infections
have mostly been conducted in hospitalized elderly adults
with medical conditions, such as cardiopulmonary diseases
[25], which may predispose them to viral infections that
are not so common in the general population. This study
involved patients who displayed speciﬁc ARTI criteria, in
Beijing, China. We tested a larger sample of the popula-
tion and detected more viral agents in parallel than did
previously published studies.
This analysis of the age distribution of viral infections
shows that younger and elderly adults were more frequently
infected. These data conform previously published data on
respiratory infections in an Australian population, where a
similar age distribution was reported [2].
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FIG. 2. Numbers of patients with positive detection of individual viruses, and detection rate (% of patients) for each month of the investigation.
(a) inﬂuenza viruses (IFVs); (b) human rhinovirus (HRV); (c) parainﬂuenza viruses (PIVs); (d) enteroviruses (EVs); (e) human coronaviruses
(HCoVs).
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As expected, IFVs were the most common agents detected
throughout the year. An epidemic of IFVA usually occurs in
the winter, and rarely in the summer, in temperate zones
[2,3]. However, during the study period, an epidemic peak of
IFV A infection was observed in the summer of 2006. More
patients with inﬂuenza-like illness were observed during this
period, reﬂected by a two-fold increase in visits to the FOCD.
The reason for this epidemic is unclear. We speculate that it
may be due to antigen drift of IFVA, but this hypothesis needs
to be conﬁrmed by haemagglutinin sequencing in future stud-
ies. Currently inﬂuenza surveillance in north China is mainly
conducted between late autumn and early spring (from 1
October to 31 March of the following year), and our ﬁndings
indicate the necessity to extend the surveillance period of IFV
to the entire year.
HRVs were the second most frequently detected respira-
tory viruses, and were found throughout the year in all age
groups, consistent with previous reports [24]. HRVs were the
most active viruses during most months, even during periods
of peak IFV activity. Moreover, HRVs represented 55.3%
(n = 52) of the co-detection cases. Previous studies have
shown that HRVs are implicated in exacerbation of diseases,
including chronic bronchitis, acute bronchiolitis, and asthma
[26–28]. Further studies are needed to assess the association
between severity of clinical symptoms and multiple infections
involving HRVs. Recently, a new group of rhinoviruses has
been associated with severe LRTIs [29,30], conﬁrming the
important role of HRVs in respiratory infections.
In this investigation, PIVs were detected at a higher rate
in LRTIs than in URTIs, and were the second most fre-
quently detected viruses in LRTIs. PIV4 was the most fre-
quently detected PIV (data not shown). Several recent
outbreaks caused by PIVs have been reported, and the inci-
dence of PIV4 infection is increasing [31], indicating the need
for further epidemiological investigation, surveillance and
control of PIV infections.
TABLE 4. Respiratory viruses detected in acute upper respiratory tract infections (URTIs) and acute lower respiratory tract
infections (LTRIs)
14–25 years 26–65 years ‡66 years Total number (%)
URTIs LRTIs URTIs LRTIs URTIs LRTIs URTIs LRTIs
Patients tested 1871 47 3275 159 386 70 5532 276
Total positives 710 (37.9)a 12 (25.5) 1088 (33.2) 43 (27.0) 129 (33.4) 28 (40.0) 1927 (34.8) 83 (30.1)
Single detections 666 (35.6) 11 (23.4) 1051 (32.1) 40 (25.2) 123 (31.9) 25 (35.7) 1840 (33.3) 76 (27.5)
Dual detections 43 (2.3) 1 (2.1) 37 (1.1) 3 (1.9) 6 (1.6) 3 (4.3) 86 (1.6) 7 (2.5)
IFV A 294 (15.7) 3 (6.4) 561 (17.1) 15 (9.4) 48 (12.4) 11 (15.7) 903 (16.3)a 29 (10.5)
IFV B 80 (4.3) 1 (2.1) 86 (2.6) 1 (0.6) 7 (1.8) 2 (2.9) 173 (3.1) 4 (1.5)
IFV C 10 (0.5) 0 5 (0.2) 0 0 0 15 (0.3) 0
HRVs 148 (7.9) 4 (8.5) 188 (5.7) 9 (5.7) 24 (6.2) 3 (4.3) 360 (6.5) 16 (5.8)
PIVs 1–4 87 (4.6) 2 (4.3) 125 (3.8) 11 (6.9) 20 (5.2) 7 (10) 232 (4.2) 20 (7.3)b
EVs 82 (4.4) 2 (4.3) 92 (2.8) 3 (1.9) 8 (2.1) 1 (1.4) 182 (3.3) 6 (2.2)
HCoVs 18 (1.0) 0 24 (0.7) 3 (1.9) 17 (4.4) 3 (4.3) 59 (1.1) 6 (2.2)
ADVs 31 (1.7) 0 16 (0.5) 3 (1.9) 1 (0.3) 0 48 (0.9) 3 (1.1)
RSV 1 (0.1) 1 (2.1) 18 (0.5) 1 (0.6) 8 (2.1) 1 (1.4) 27 (0.5) 3 (1.1)
HMPV 4 (0.2) 0 10 (0.3) 0 2 (0.5) 3 (4.3) 16 (0.3) 3 (1.1)
ADV, adenovirus; EV, enterovirus; HCoV, human coronavirus; HMPV, human metapneumovirus; HRV, human rhinovirus; IFV, inﬂuenza virus; PIV, parainﬂuenza virus; RSV,
respiratory syncytial virus.
aNumbers in parentheses are percentages.
bRepresents signiﬁcant difference between the incidence of virus infection by chi-square test.
TABLE 3. Co-detection of respiratory viruses in adults with
acute respiratory tract infections
Virus co-detection
status
Positive cases among age groups
Total
cases,
n = 5808
14–25
years,
n = 1918
26–65
years,
n = 3434
‡66
years,
n = 456
IFV A + PIVs 4 5 0 9
IFV A + EVs 3 3 0 6
IFV A + HRVs 4 14 2 20
IFV A + HCoVs 1 0 0 1
IFV A + HMPV 1 0 0 1
IFV A + IFV C 2 0 0 2
IFV B + PIVs 1 1 1 3
IFV B + EVs 2 2 0 4
IFV B + HRVs 6 3 1 10
IFV B + ADVs 1 0 0 1
IFV B + HMPV 0 1 0 1
IFV B + IFV C 2 1 0 3
PIVs + EVs 2 3 0 5
PIVs + HRVs 4 2 0 6
PIVs + ADVs 1 0 0 1
PIVs + HCoVs 0 0 2 2
PIVs + RSV 0 0 1 1
PIVs + HMPV 0 0 1 1
EVs + HRVs 4 2 1 7
EVs + HCoVs 0 1 0 1
HRVs + ADVs 3 1 0 4
HRVs + HCoVs 3 1 0 4
HRVs + IFV B + PIVs 1 0 0 1
Total 45 (2.3)a 40 (1.2) 9 (2.0) 94 (1.6)
ADV, adenovirus; EV, enterovirus; HCoV, human coronavirus; HMPV, human
metapneumovirus; HRV, human rhinovirus; IFV, inﬂuenza virus; PIV, parainﬂu-
enza virus; RSV, respiratory syncytial virus.
aNumbers in parentheses are percentages.
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HCoVs have recently received special attention because
of the discovery and threat of SARS-CoV [8]. In this study,
positive cases were found for all known HCoV types except
SARS-CoV, including HCoV OC43, 229E, NL63, and HKU1.
HCoVs were more frequently detected in elderly adults,
consistent with the ﬁndings of Falsey et al. [32].
The prevalence of respiratory virus co-infection in adults
was lower than that in children [33–36]. The clinical signiﬁ-
cance of such co-detection is unclear. It is possible that
respiratory viruses may persist in the nasopharyngeal tract
for a long period without causing symptoms [37]. In addition,
molecular assays allow the detection of viral nucleic acid
materials even if the virus has no replication ability. The
ampliﬁcation of residual genetic material from previous infec-
tions or from persistent viruses also remains a complicating
factor in the interpretation of multiple virus detection [15].
In summary, the spectrum, seasonality, age distribution
and clinical associations of respiratory virus infections in
adults with ARTIs were analysed in this study. The ﬁndings
provide baseline data for evaluating the burden of respiratory
virus infection in adults. As the number of patients with
LRTIs was limited in this analysis, further studies should
be undertaken and longer surveillance periods should
provide more information concerning the epidemiology of
respiratory virus infections, and their relationships with
clinical outcomes.
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